Insights

Product Innovation Piramal Critical Care continuously expands its injectable portfolio with new launches such as Edaravone IV Infusion, Pantoprazole Sodium, Doxycycline, and Zinc Sulfate, demonstrating a strong pipeline and commitment to critical care markets that can be leveraged for upselling and cross-selling opportunities.

Market Differentiation As the first-to-market generic Edaravone IV Infusion, Piramal Critical Care positions itself as an innovative leader in the critical injectable segment, which can attract healthcare providers seeking advanced and differentiated products.

Growth Focus The company’s recent product launches and portfolio expansion efforts indicate a strategic focus on increasing market share in critical care injectable drugs within the U.S., offering potential opportunities to engage with hospitals and healthcare systems investing in specialized treatments.

Operational Expansion With a growing executive team including a new President and COO, Jeffrey Hampton, Piramal Critical Care is strengthening its operational capabilities, which can translate into improved customer support and expanded sales channels for targeted outreach.

Technology Adoption Utilizing advanced tech tools like Power BI, QlikView, and cloud platforms such as Microsoft Azure, the company is optimizing data-driven decision-making processes, providing opportunities for tailored product proposals based on healthcare providers’ analytics and buying patterns.

Minrad Tech Stack

Minrad uses 8 technology products and services including Site Kit, QlikView, Power BI, and more. Explore Minrad's tech stack below.

  • Site Kit
    Analytics
  • QlikView
    Business Intelligence
  • Power BI
    Business Intelligence
  • Microsoft Access
    Database Management Software
  • MasterControl
    Document Management Systems
  • Microsoft
    Miscellaneous
  • Microsoft Azure
    Platform As A Service
  • Smartsheet
    Project Management

Media & News

Minrad's Email Address Formats

Minrad uses at least 2 format(s):
Minrad Email FormatsExamplePercentage
FLast@minrad.comJDoe@minrad.com
100%

Frequently Asked Questions

Where is Minrad's headquarters located?

Minus sign iconPlus sign icon
Minrad's main headquarters is located at United States. The company has employees across 2 continents, including North AmericaEurope.

What is Minrad's official website and social media links?

Minus sign iconPlus sign icon
Minrad's official website is piramalcriticalcare.com and has social profiles on LinkedIn.

What is Minrad's NAICS code?

Minus sign iconPlus sign icon
Minrad's NAICS code is 3391 - Medical Equipment and Supplies Manufacturing.

How many employees does Minrad have currently?

Minus sign iconPlus sign icon
As of December 2025, Minrad has approximately 51 employees across 2 continents, including North AmericaEurope. Key team members include President & Ceo: D. D.Safety Manager: W. A.Sales Rep: D. C.. Explore Minrad's employee directory with LeadIQ.

What industry does Minrad belong to?

Minus sign iconPlus sign icon
Minrad operates in the Medical Equipment Manufacturing industry.

What technology does Minrad use?

Minus sign iconPlus sign icon
Minrad's tech stack includes Site KitQlikViewPower BIMicrosoft AccessMasterControlMicrosoftMicrosoft AzureSmartsheet.

What is Minrad's email format?

Minus sign iconPlus sign icon
Minrad's email format typically follows the pattern of FLast@minrad.com. Find more Minrad email formats with LeadIQ.
Minrad logo

Minrad

Medical Equipment ManufacturingUnited States51-200 Employees

Minrad operates in the medical equipment manufacturing sector in the United States, with a focus on providing injectable and critical care products through its parent brand, Piramal Critical Care. The company’s portfolio includes a range of injectable medications used in acute and intensive care settings, expanding its offerings through periods of product launches to broaden the scope of generic injectables available in the U.S. market. Its customer base comprises healthcare providers and facilities that require ready-to-use intravenous therapies for critical care, with product introductions aimed at enhancing treatment options in hospital environments. Based in the United States and part of Piramal Pharma’s critical care division, Minrad situates itself within the broader life sciences equipment and pharmaceutical supply chain, contributing to the availability of essential injectable medications. A notable recent development involves the launch of Edaravone IV Infusion and other injectables, reflecting ongoing portfolio expansion in the critical care space. Although specific market metrics are not disclosed, the company operates with a size indicative of a mid-sized organization within the medical equipment manufacturing landscape.

Section iconCompany Overview

Headquarters
United States
NAICS Code
3391 - Medical Equipment and Supplies Manufacturing
Employees
51-200

Section iconFunding & Financials

  • $50M$100M

    Minrad's revenue is estimated to be in the range of $50M$100M

Section iconFunding & Financials

  • $50M$100M

    Minrad's revenue is estimated to be in the range of $50M$100M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.